Enzymatic metal oxide/nanoparticle heterojunctions with mutually reinforced bifunctional chemotherapies for combating drug-resistant bacteria

Qian Zhou,Ting Wang,Zhenyu Xing,Raul D. Rodriguez,Liang Cheng,Yang Gao,Qiu Chen,Chong Cheng
DOI: https://doi.org/10.1016/j.cej.2024.149249
IF: 15.1
2024-02-08
Chemical Engineering Journal
Abstract:Non-healing diabetic wounds caused by continuous bacterial infections comprise one of the main complications in individuals with diabetes, posing a significant risk that often results in limb amputation. The growing concern of antibiotic resistance has prompted the exploration of non-antibiotic strategies to combat bacteria effectively. Here, an Ag-doped V 2 O 5 (Ag-V 2 O 5 ) heterojunction biocatalyst is designed to act as an artificial enzyme for the catalytic treatment of bacterial infections in rats' skin wounds through the bifunctional chemotherapies of reactive oxygen species (ROS) and Ag + . Experimental analyses confirm that the Ag-V 2 O 5 catalyst exhibits exceptional peroxidase (POD)-mimetic performance, with a V max value of 2.66 μM s −1 and a turnover number of 200.88×10 -3 s −1 , surpassing most POD-mimetic catalysts. Furthermore, the Ag-V 2 O 5 exhibits remarkable Ag + leaching capabilities, attributed to its high V 5+ /V 4+/3+ ratio and weak metal-support interactions. Benefiting from the bifunctional chemotherapies of ROS and Ag + , the Ag-V 2 O 5 exhibits a low minimal inhibition concentration (32 μg/mL Ag-V 2 O 5 ) against S. aureus and effectively promotes wound healing. The innovative strategy of bifunctional chemotherapies on valence-modulated Ag + release and ROS-catalysis represents a significant leap forward in chronic wound treatment, inspiring future breakthroughs in biomedical therapeutics based on Ag + and ROS.
engineering, chemical, environmental
What problem does this paper attempt to address?